Tag: Alzheimer’s
Alzheimer Disease Associated With Greater Neural Flexibility
Neural flexibility also predicts dementia transition
Sense of Life Purpose Lowers Risk for Cognitive Impairment
Findings persisted even among people at high genetic risk for dementia
FDA Approves Subcutaneous Leqembi for Treatment of Early Alzheimer Disease
Leqembi Iqlik allows for at-home maintenance dosing after initial 18 months of intravenous dosing
Mediterranean Diet Beneficial in Those With High Alzheimer Disease Risk
Adherence to the Mediterranean diet more effectively modulates dementia-related metabolites in APOE4 homozygotes
Lifestyle Interventions Improve Cognition for At-Risk Older Adults
Significantly greater benefit on global cognition seen for structured versus self-guided intervention over two years
GLP-1 Receptor Agonists Tied to Decrease in T2DM-Related Dementia Risk
GLP-1 receptor agonist use linked to lower risk for overall dementia, Alzheimer disease, nonvascular dementia compared with metformin
Greater Neighborhood Disadvantage Tied to Inflammatory, Alzheimer Disease Biomarkers
Cross-sectional association seen for greater neighborhood disadvantage with CSF chitinase-3-like protein 1 and tau
Triglyceride-Glucose Index May Predict Faster Cognitive Decline in Early Phases of Alzheimer Disease
High triglyceride-glucose index significantly associated with faster cognitive decline in the MCI-Alzheimer disease subgroup
Late-Life Mood Disorders May Indicate Predisposition to Dementia
Participants with LLMDs more likely to be tau PET- and amyloid β PET-positive compared with healthy controls
Lower Risk of Alzheimer Disease Seen for Breast Cancer Survivors
In landmark analyses, lower risk did not persist beyond five years of survival
